Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q100545555
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010752.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q100545555
|
024
|
|
|
‡a
0000-0001-6918-1450
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q100545555
|
100
|
0 |
|
‡a
Ángela Martina Montero Moretón
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Ángela Martina Montero Moretón
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's PROSPECTIVE COMPARATIVE STUDY OF THE TREATMENT OF HELICOBACTER PYLORI WITH ANTIBIOTIC SUSCEPTIBILITY TESTING-GUIDED TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY WITH PYLERA®
|
670
|
|
|
‡a
Author's PROSPECTIVE COMPARATIVE STUDY OF THE TREATMENT OF HELICOBACTER PYLORI WITH ANTIBIOTIC SUSCEPTIBILITY TESTING-GUIDED TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY WITH PYLERA®
|
670
|
|
|
‡a
Author's Sweet syndrome in severe ulcerative flare
|
909
|
|
|
‡a
(orcid) 0000000169181450
‡9
1
|
919
|
|
|
‡a
sweetsyndromeinsevereulcerativeflare
‡A
Sweet syndrome in severe ulcerative flare
‡9
1
|
919
|
|
|
‡a
prospectivecomparativestudyofthetreatmentofhelicobacterpyloriwithantibioticsusceptibilitytestingguidedtripletherapycomparedtoquadrupletherapywithpyleraa
‡A
PROSPECTIVE COMPARATIVE STUDY OF THE TREATMENT OF HELICOBACTER PYLORI WITH ANTIBIOTIC SUSCEPTIBILITY TESTING-GUIDED TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY WITH PYLERA®
‡9
1
|
919
|
|
|
‡a
prospectivecomparativestudyofthetreatmentofhelicobacterpyloriwithantibioticsusceptibilitytestingguidedtripletherapycomparedtoquadrupletherapywithpylera
‡A
PROSPECTIVE COMPARATIVE STUDY OF THE TREATMENT OF HELICOBACTER PYLORI WITH ANTIBIOTIC SUSCEPTIBILITY TESTING-GUIDED TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY WITH PYLERA®
‡9
1
|
996
|
|
|
‡2
LC|nb2017017407
|
996
|
|
|
‡2
ISNI|0000000052237975
|
996
|
|
|
‡2
LC|nb2005003150
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|